[{"address1": "500 Unicorn Park Drive", "address2": "Suite 303", "city": "Woburn", "state": "MA", "zip": "01801", "country": "United States", "phone": "781 222 9600", "website": "https://www.replimune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.", "fullTimeEmployees": 479, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sushil  Patel Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 1063402, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily Luisa Hill", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 752024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Konstantinos  Xynos M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2025, "totalPay": 781936, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Astley-Sparke F.S.A.", "age": 54, "title": "Executive Chairman", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 960520, "exercisedValue": 0, "unexercisedValue": 435967}, {"maxAge": 1, "name": "Mr. Andrew  Schwendenman", "age": 49, "title": "Chief Accounting Officer & Treasurer", "yearBorn": 1976, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn  Glidden J.D.", "title": "Senior VP & General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camilo  Garcia M.A., M.B.A.", "title": "Chief Human Resource Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Sarchi", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Bullock", "title": "Chief Manufacturing Officer & Framingham Site Head", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nina  Aragam", "title": "Senior Vice President of Portfolio Strategy & Program Management", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.23, "open": 8.28, "dayLow": 7.96, "dayHigh": 8.545, "regularMarketPreviousClose": 8.23, "regularMarketOpen": 8.28, "regularMarketDayLow": 7.96, "regularMarketDayHigh": 8.545, "payoutRatio": 0.0, "beta": 0.732, "forwardPE": -3.8933332, "volume": 1096264, "regularMarketVolume": 1096264, "averageVolume": 3922650, "averageVolume10days": 1179760, "averageDailyVolume10Day": 1179760, "bid": 7.0, "ask": 12.16, "bidSize": 2, "askSize": 2, "marketCap": 629899968, "fiftyTwoWeekLow": 2.68, "fiftyTwoWeekHigh": 14.795, "allTimeHigh": 54.85, "allTimeLow": 2.68, "fiftyDayAverage": 9.4641, "twoHundredDayAverage": 7.929625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 382579968, "profitMargins": 0.0, "floatShares": 52846490, "sharesOutstanding": 78443334, "sharesShort": 14761596, "sharesShortPriorMonth": 16697152, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1882, "heldPercentInsiders": 0.02328, "heldPercentInstitutions": 1.0655999, "shortRatio": 8.52, "shortPercentOfFloat": 0.35189998, "impliedSharesOutstanding": 78443334, "bookValue": 3.359, "priceToBook": 2.3905923, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -310263008, "trailingEps": -3.47, "forwardEps": -2.0625, "enterpriseToEbitda": -1.222, "52WeekChange": -0.2626263, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 8.03, "targetHighPrice": 18.0, "targetLowPrice": 10.0, "targetMeanPrice": 12.57143, "targetMedianPrice": 12.0, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 323644000, "totalCashPerShare": 4.126, "ebitda": -312951008, "totalDebt": 76324000, "quickRatio": 6.152, "currentRatio": 6.309, "debtToEquity": 28.984, "returnOnAssets": -0.44827998, "returnOnEquity": -0.96236, "freeCashflow": -161465120, "operatingCashflow": -262672000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "REPL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Replimune Group, Inc.", "longName": "Replimune Group, Inc.", "fiftyTwoWeekLowChange": 5.3499994, "fiftyTwoWeekLowChangePercent": 1.9962684, "fiftyTwoWeekRange": "2.68 - 14.795", "fiftyTwoWeekHighChange": -6.7650003, "fiftyTwoWeekHighChangePercent": -0.4572491, "fiftyTwoWeekChangePercent": -26.262629, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1747915200, "earningsCallTimestampEnd": 1747915200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.47, "epsForward": -2.0625, "epsCurrentYear": -3.36803, "priceEpsCurrentYear": -2.384183, "fiftyDayAverageChange": -1.4341002, "fiftyDayAverageChangePercent": -0.15153053, "twoHundredDayAverageChange": 0.1003747, "twoHundredDayAverageChangePercent": 0.01265819, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532093400000, "postMarketChangePercent": 0.046080403, "postMarketPrice": 8.0337, "postMarketChange": 0.0037002563, "regularMarketChange": -0.2, "regularMarketDayRange": "7.96 - 8.545", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3922650, "corporateActions": [], "postMarketTime": 1768006152, "regularMarketTime": 1767992401, "exchange": "NMS", "messageBoardId": "finmb_571664452", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.43013, "regularMarketPrice": 8.03, "displayName": "Replimune", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]